Concepedia

Publication | Open Access

FP13.04 KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ Locally Advanced/Metastatic NSCLC

28

Citations

0

References

2021

Year

No additional data available for this publication yet. Check back later!